DiRocco Derek is a director of Werewolf Therapeutics Inc.
Person profile
Roles
Address
San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
89bio, Inc.
5 Feb 24
4
Werewolf Therapeutics, Inc.
23 Jun 23
4
iTeos Therapeutics, Inc.
15 Jun 23
4
Mineralys Therapeutics, Inc.
13 Feb 23
4
89bio, Inc.
13 Feb 23
3
Mineralys Therapeutics, Inc.
9 Feb 23
4
Acrivon Therapeutics, Inc.
16 Nov 22
3
Acrivon Therapeutics, Inc.
9 Nov 22
4
iTeos Therapeutics, Inc.
10 Jun 22
4
Werewolf Therapeutics, Inc.
3 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Feb 24 | ETNB 89bio | Stock Option Common Stock | Grant | Acquire A | No | No | 9.98 | 45,150 | 450.60 k | 45,150 |
21 Jun 23 | HOWL Werewolf Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.81 | 13,200 | 37.09 k | 13,200 |
13 Jun 23 | ITOS ITeos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 14.77 | 22,383 | 330.60 k | 22,383 |
9 Feb 23 | ETNB 89bio | Stock Option Common Stock | Grant | Acquire A | No | No | 14.7 | 27,400 | 402.78 k | 27,400 |